Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Prince

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancerDerrick Wansom, Emily Light, Frank Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6Elizabeth A Van Tubergen, Rajat Banerjee, Min Liu, et al.
Head & Neck|February 17, 2016
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinomaNghia Nguyen, Emily Bellile, Daffyd Thomas, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
Seminars in Cancer Biology|November 23, 2015
Designing a broad-spectrum integrative approach for cancer prevention and treatmentKeith I Block, Charlotte Gyllenhaal, Leroy Lowe, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancerDerrick Wansom, Emily Light, Frank Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6Elizabeth A Van Tubergen, Rajat Banerjee, Min Liu, et al.
Head & Neck|February 17, 2016
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinomaNghia Nguyen, Emily Bellile, Daffyd Thomas, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
Seminars in Cancer Biology|November 23, 2015
Designing a broad-spectrum integrative approach for cancer prevention and treatmentKeith I Block, Charlotte Gyllenhaal, Leroy Lowe, et al.
Pageof 3